Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

GnRH treatment can reduce breast cancer cell invasion.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Low-dose Buserelin effectively reduces hirsutism with minimal side effects.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

Metformin can start ovulation and may lower 17P response in PCOS, but six months is too short to improve hair growth or change body fat distribution.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Prenatal antiandrogen treatment altered hormone levels in adult spotted hyenas, affecting males and females differently.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Some medicines can reduce excessive hair growth in women, but more research is needed to compare treatments and consider side effects.

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

Most patients improved with oral contraceptives, but some needed additional treatment.

Most women with too much androgens have PCOS, which can be managed with birth control pills, medication for hair growth, and fertility treatments, and losing weight helps too.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Early puberty is more common in girls and African-American children, possibly due to nutrition, obesity, stress, and environmental factors, and is treated with hormone therapy.

Low prolactin levels in PCOS can cause metabolic problems like insulin resistance and obesity.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

Male hormones and their interactions are crucial for male sexual development and characteristics.

Elagolix did not effectively treat polycystic ovary syndrome.